The estimated Net Worth of Renee M Luhr is at least $1.44 Million dollars as of 31 December 2008. Renee Luhr owns over 1,875 units of Omnicell stock worth over $888,319 and over the last 19 years Renee sold OMCL stock worth over $549,541.
Renee has made over 15 trades of the Omnicell stock since 2006, according to the Form 4 filled with the SEC. Most recently Renee sold 1,875 units of OMCL stock worth $23,138 on 31 December 2008.
The largest trade Renee's ever made was exercising 34,368 units of Omnicell stock on 6 November 2006 worth over $400,731. On average, Renee trades about 8,210 units every 44 days since 2006. As of 31 December 2008 Renee still owns at least 20,625 units of Omnicell stock.
You can see the complete history of Renee Luhr stock trades at the bottom of the page.
Renee's mailing address filed with the SEC is 1201 CHARLESTON ROAD, , MOUNTAIN VIEW, CA, 94043.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps, and Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: